To include your compound in the COVID-19 Resource Center, submit it here.

Experimental GBM vaccine available under U.S. right-to-try program

ERC is making its experimental glioblastoma multiforme vaccine Gliovac available to patients under a program based on the federal right-to-try law.

The company is the first to develop an experimental therapy program to treat patients under RTT since

Read the full 386 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE